PHYT Med Spa
US$ 20.89
glp 1/gip agonist GLP-1/GIP Receptor Agonists and Diabetic Retinopathy: What ODs Should Know Mechanisms of action and therapeutic
Description
Curr Opin Endocrinol Diabetes Obes (2013) 20(2):8797
& Ruus, R
PMC 12739101
These recommendations are very consistent with the key points from the most current international guidelines, especially those published, in 2024 and 2025, by multi-society groups in both the US and the UK 1-3
Research into the area is far from complete
However, before starting Medicare with a Part D policy (P.B
